Stanford Spinout SiteOne Therapeutics Gets Funding
SiteOne Therapeutics, a Stanford University spinout developing treatments for acute and chronic pain, said last week that it has received a round of funding. Size of the funding for the company was not announced. SiteOne Therapeutics said the funding was led by Next Frontier Capital, and also included 2M Companies Inc., Sears Capital Management, Biobrit LLC, Mission Bay Capital and Z Investments. SiteOne Therapeutics is based in Bozeman, Montana. SiteOne says it has and exclusive license from Stanford University for its technology.
posted on Monday, July 20, 2015 (Link to more information)
Related companies:
Stanford
Related stories:
> SiteOne Therapeutics Raises $15M
> Amprius Powers Up With $30M
> Inscopix Finds $10M For Brain Mapping Tools
> True North Therapeutics Gets $22M
> Aromyx Aims At $3.6M Funding Via Crowdfunding Site
silicontap.com Home